Updates in Breast Cancer Management Symposium

Saturday, September 6, 2025, 8:30 AM - 4:00 PM EST, Vanguard Hotel, Ann Arbor, MI


AMA PRA Category 1 Credits™ (6.50 hours), Non-Physician Attendance (6.50 hours)

The Michigan Medicine Rogel Cancer Center (UMRCC) is an NCI-designated comprehensive cancer center with a history of excellence in cancer care, education, and research. The UMRCC catchment area includes the entire State of Michigan, its ˜10M residents, and ˜750 community medical oncologists. The Mission of the UMRCC is to reduce the burden of cancer and advance health equity through transdisciplinary collaboration in research, education, patient care and community outreach. The mission of the University of Michigan Rogel Cancer Center is to reduce the burden of cancer and advance health equity through transdisciplinary collaboration in research, education, patient care and community outreach. Join us for an engaging educational session by the University of Michigan Rogel Cancer Center, designed to enhance your expertise in breast cancer care. Learn about the latest advances in local and systemic therapies, management of young-onset and metastatic breast cancer, strategies for handling treatment toxicities, and best practices for using ctDNA testing in clinical practice. Don’t miss this opportunity to improve outcomes for your patients!

1. Apply recent paradigm shifts in locoregional therapy recommendations for patients with early-stage breast cancer.
2. Appreciate the rapidly evolving therapeutic landscape across the spectrum of breast cancers, including the increased utilization of novel therapies.
3. Identify impactful research findings, specifically with regards to the use of circulating tumor DNA to monitor disease status or detect therapeutically relevant genomic alterations.

Please click website link to register: 
https://umich.irisregistration.com/Form/UBCMS2025

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Accessibility Statement
The University of Michigan Medical School is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Activity Coordinator.

Questions? Please contact Darla Kroft ([email protected]) 734-763-5567

Mitigation of Relevant Financial Relationships

The University of Michigan Medical School adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a CE activity, including faculty, planners, or others are required to disclose all relevant financial relationships with ineligible entities. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Saturday, September 6, 2025